| Wissenschaftl. Titel | A Multicenter, Randomized, Parallel-Group, Double-Blind, Active-Controlled Study to evaluate the efficacy and safety of Bimekizumab compared to Ustekinumab in Children and Adolescents from 6 years to less than 18 years of age with moderate to severe Plaque Psoriasis |
| Erkrankung |
Haut:
Schuppenflechte (Psoriasis)
|
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
| Links | Zu den Ein- und Ausschlusskriterien |
erstellt 07.11.2024 Admin04
geändert 05.12.2024 Admin07